ArticleBritish journal of clinical pharmacology2019

Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients.

Tore Haslemo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.